Humacyte's mission is to become a leader in novel, off-the-shelf extracellular matrix tissue products, especially those that could provide life-saving improvements in treatments for vascular conditions. Because Humacyte grows these tissue replacements in vitro from banked vascular cells that are decellularized, its products do not require cells from the patient and can be easily stored until patients and their surgeons need them. Founded in 2004, Humacyte is a privately held company led by experts in clinical trials, regulatory affairs, business and commercial development, finance and intellectual property management. Humacyte is headquartered in Morrisville, North Carolina.